TriNetX®, a leader in powering lifesaving discoveries with global real-world data and real-world evidence insights, announced today that its TriNetX LIVE™ platform has been awarded high-level National Security Scheme Esquema Nacional de Seguridad (ENS) certification, established by the Spanish government, for fully adhering to ENS standards in the protection and governance of its clients’ healthcare data.
With the rapid digitization of patient records and growing reliance on electronic systems, data security in healthcare is paramount. Globally, healthcare is the third most cyberattacked industry, experiencing nearly 2,000 attacks per week. In addition to jeopardizing patient privacy and putting care delivery at risk, these cyberattacks and other data security issues cost the global healthcare industry more than any other business sector — nearly $10 million U.S. per breach between March 2023 and February 2024.
ENS addresses data security by offering a framework to ensure the protection of information systems and data across public administrations and the private entities that interact with them. Aligning with broader European standards such as the General Data Protection Regulation (GDPR), ENS sets out a series of principles and requirements for security measures covering risk management, compliance, and incident response. Certification demonstrates an organization has implemented robust security practices.
“The protection of our healthcare network’s highly sensitive patient data is an absolute priority,” said Gadi Lachman, President and CEO of TriNetX. “We couldn’t be prouder of our ENS certification as it solidifies our steadfast commitment, diligence, and ability to adapt to the challenges of securing healthcare data for the benefit of clinical research and drug discovery worldwide in an environment that’s constantly evolving.”
The ENS-certified TriNetX LIVE™ platform, the healthcare industry’s largest global health research network for conducting real-world evidence studies, is used by researchers around the world to analyze clinical trial protocols across hundreds of therapeutic areas and present thousands of clinical trial opportunities to TriNetX healthcare organization members.
